1-苄氧基-4-溴-2-异丙基苯 | 169247-38-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-苄氧基-4-溴-2-异丙基苯
• 英文名称: 1-benzyloxy-4-bromo-2-isopropyl-benzene
• 英文别名: 1-(Benzyloxy)-4-bromo-2-isopropylbenzene；4-bromo-1-phenylmethoxy-2-propan-2-ylbenzene
• CAS: 169247-38-5
• 化学式: C₁₆H₁₇BrO
• 分子量: 305.214
• InChiKey: JNRHGWQQDMEQPD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-苄氧基-4-溴-2-异丙基苯 在 palladium on activated charcoal 正丁基锂 、 氢气 、 potassium carbonate 作用下， 以 四氢呋喃 、 乙醇 、 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， -78.0~20.0 ℃ 、101.33 kPa 条件下， 反应 16.5h， 生成 trifluoro-methanesulfonic acid 4-(2,6-dimethyl-4-triisopropylsilanyloxy-benzyl)-2-isopropyl-phenyl ester
  参考文献：
  名称：

  A Functionally Orthogonal Ligand−Receptor Pair Created by Targeting the Allosteric Mechanism of the Thyroid Hormone Receptor

  摘要：

  Nuclear receptors are ligand-dependent transcription factors that are of interest as potential tools to artificially regulate gene expression. Ligand binding induces a conformational change involving helix-12 which forms part of the dimerization interface used to bind transcriptional coactivators. When triiodothyronine (T3) binds the thyroid hormone receptor (TR) it indirectly contacts helix-12 through intermediary residues His(435) and Phe(451) termed a His-Phe switch. The mutant TR beta(H435A) is nonresponsive to physiological concentrations of T3 but can be activated by the synthetic hormone analogue QH2 which potently activates His435 -> Ala mutant at concentrations that do not activate the wild-type receptors TR alpha and TR beta. QH2 does not show antagonist behavior with the wild-type TRs. QH2's functionally orthogonal behavior with TR beta(H435A) is preserved on the three consensus thyroid hormone response elements.

  DOI：

  10.1021/ja060760v
• 作为产物：
  描述：

  异丙苯酚 在 溴 、 potassium carbonate 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.08h， 生成 1-苄氧基-4-溴-2-异丙基苯
  参考文献：
  名称：

  一种甲状腺激素受体β激动剂及其应用

  摘要：

  本发明属于医药技术领域，具体涉及一种甲状腺激素受体β激动剂及其应用，该激动剂含有式(I)所示化合物和/或其药学上可接受的衍生物， 本发明提供的化合物或/和其药学上可接受的盐、酯、溶剂化物、水合物、异构体、晶型或其前药可用于治疗和/或预防与THR‑β活性有关的疾病，与现有技术相比，本发明的甲状腺激素受体β激动剂化合物在体内吸收效果更好，血药浓度更高，有利于化合物产生更好的抗NASH效果。

  公开号：

  CN115974925A

文献信息

• NOVEL 6-5 BICYCIC HETEROCYCLIC DERIVATIVE AND MEDICAL USE THEREOF
  申请人：Sanwa Kagaku Kenkyusho Co., Ltd

  公开号：EP2036887A1

  公开（公告）日：2009-03-18

  An object of the present invention is to provide a medicament as a thyroid hormone receptor ligand which is sufficient in drug efficacy and safety, and has the excellent action as a drug. The present invention provides a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: [wherein [Chemical Formula 2] is a single bond or a double bond; A is -CH2- or -CO-; X, Y, and Z are each independently a nitrogen atom or a carbon atom; R1 is a hydrogen atom or an aralkyl group; R2 is an alkyl group or an aralkyl group, etc.; R3 is a hydrogen atom or an alkyl group, etc.; R4 is a hydrogen atom or an alkyl group; R5 is a hydrogen atom, an alkyl group or a halo lower alkyl group, etc.; R6 is a hydrogen atom or an alkyl group; R7 is a hydrogen atom, etc.; R8 is a hydrogen atom, or an alkyl group, etc.; and E is -NHCO-G-COR12, etc. (wherein G is a single bond or an alkylene group, and R12 is a hydroxy group or an alkoxy group)].

  本发明的目的是提供一种药物，作为甲状腺激素受体配体，其在药物疗效和安全性上足够，并且具有作为药物的优秀作用。本发明提供了一种由以下通式（I）表示的化合物或其药用可接受的盐：[其中[化学公式2]是单键或双键；A是-CH2-或-CO-；X、Y和Z各自独立为氮原子或碳原子；R1是氢原子或芳烷基团；R2是烷基团或芳烷基团等；R3是氢原子或烷基团等；R4是氢原子或烷基团；R5是氢原子、烷基团或卤素低烷基团等；R6是氢原子或烷基团；R7是氢原子等；R8是氢原子或烷基团等；E是-NHCO-G-COR12等（其中G是单键或亚烷基团，R12是羟基或烷氧基）]。
• Dihaloprene compound, insecticide/acaricide containing said
  申请人：Sumitomo Chemical Company, Limited

  公开号：US05530015A1

  公开（公告）日：1996-06-25

  There is disclosed a dihalopropene compound of the formula I: ##STR1## wherein l is an integer of 1 to 5; m is an integer of 1 to 4; R.sup.1 's and R.sup.2 's are the same or different and are independently halogen or various other groups; D is oxygen; X's are the same or different and are independently chlorine or bromine; Y is oxygen; Z, P and Q are the same or different and are independently nitrogen or CH, provided that P and Q are not simultaneously nitrogen, and when Y is sulfur, Z is CH. Also disclosed is an insecticide/acaricide comprising the dihalopropene compound as an active ingredient. The dihalopropene compound exhibits excellent insecticidal/acaricidal action. Further disclosed is an intermediate compound for use in the production of the dihalopropene compound.

  公开了一种具有以下结构的二卤代丙烯化合物：其中l为1到5的整数；m为1到4的整数；R^1和R^2相同或不同且独立地为卤素或其他各种基团；D为氧；X相同或不同且独立地为氯或溴；Y为氧；Z、P和Q相同或不同且独立地为氮或CH，但P和Q不能同时为氮，当Y为硫时，Z为CH。公开了一种含有上述二卤代丙烯化合物作为活性成分的杀虫剂/杀螨剂。该二卤代丙烯化合物表现出优异的杀虫/杀螨作用。还公开了用于生产上述二卤代丙烯化合物的中间体化合物。
• 一种具有甲状腺激素受体激动剂特性的肝靶 向化合物及其药物组合物
  申请人：厦门甘宝利生物医药有限公司

  公开号：CN111116684B

  公开（公告）日：2020-09-25

  本发明属于生物医药领域，具体涉及靶向药物领域，更具体地说，本发明涉及一种具有甲状腺激素受体激动剂特性的肝靶向化合物及其药物组合物，该化合物为式(1)所示的化合物。该化合物可用于治疗和/预防由甲状腺激素调节失调引起的疾病，也可以有效降低血浆及肝脏细胞中的脂质。
• Intermediate compound for use in production of dihalopropene compound
  申请人：Sumitomo Chemical Company, Limited

  公开号：US05698702A1

  公开（公告）日：1997-12-16

  There is disclosed a dihalopropene compound of the formula I: ##STR1## wherein l is an integer of 1 to 5; m is an integer of 1 to 4; R.sup.1 's and R.sup.2 's are the same or different and are independently halogen or various other groups; D is oxygen; X's are the same or different and are independently chlorine or bromine; Y is oxygen; Z, P and Q are the same or different and are independently nitrogen or CH, provided that P and Q are not simultaneously nitrogen, and when Y is sulfur, Z is CH. Also disclosed is an insecticide/acaricide comprising the dihalopropene compound as an active ingredient. The dihalopropene compound exhibits excellent insecticidal/acaricidal action. Further disclosed is an intermediate compound for use in the production of the dihalopropene compound.

  本发明披露了一种式为I的二卤代丙烯化合物：##STR1## 其中，l是1至5的整数；m是1至4的整数；R.sup.1 's和R.sup.2 's相同或不同，且独立地是卤素或其他不同基团；D是氧；X's相同或不同，且独立地是氯或溴；Y是氧；Z、P和Q相同或不同，且独立地是氮或CH，但当Y是硫时，Z是CH。本发明还披露了一种包含上述二卤代丙烯化合物作为活性成分的杀虫剂/杀螨剂。该二卤代丙烯化合物表现出优异的杀虫/杀螨作用。此外，本发明还披露了一种中间体化合物，用于制备上述二卤代丙烯化合物。
• NOVEL 6-5 SYSTEM BICYCLIC HETEROCYCLIC DERIVATIVE AND ITS PHARMACEUTICAL UTILITY
  申请人：Asano Yukiyasu

  公开号：US20090176841A1

  公开（公告）日：2009-07-09

  An object of the present invention is to provide a medicament as a thyroid hormone receptor ligand which is sufficient in drug efficacy and safety, and has the excellent action as a drug. The present invention provides a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: [wherein [Chemical Formula 2] is a single bond or a double bond; A is —CH 2 — or —CO—; X, Y, and Z are each independently a nitrogen atom or a carbon atom; R 1 is a hydrogen atom or an aralkyl group; R 2 is an alkyl group or an aralkyl group, etc.; R 3 is a hydrogen atom or an alkyl group, etc.; R 4 is a hydrogen atom or an alkyl group; R 5 is a hydrogen atom, an alkyl group or a halo lower alkyl group, etc.; R 6 is a hydrogen atom or an alkyl group; R 7 is a hydrogen atom, etc.; R 8 is a hydrogen atom, or an alkyl group, etc.; and E is —NHCO-G-COR 12 , etc. (wherein G is a single bond or an alkylene group, and R 12 is a hydroxy group or an alkoxy group)].

  本发明的目的是提供一种作为甲状腺激素受体配体的药物，具有充分的药效和安全性，并具有优秀的药物作用。本发明提供了以下通式（I）所表示的化合物或其药学上可接受的盐：[其中[化学式2]是单键或双键；A是-CH2-或-CO-；X、Y和Z分别是氮原子或碳原子；R1是氢原子或芳基烷基；R2是烷基或芳基烷基等；R3是氢原子或烷基等；R4是氢原子或烷基；R5是氢原子、烷基或卤代低烷基等；R6是氢原子或烷基；R7是氢原子等；R8是氢原子或烷基等；E是-NHCO-G-COR12等（其中G是单键或烷基亚基，R12是羟基或烷氧基）]。